Search

Your search keyword '"Leitch, Heather"' showing total 495 results

Search Constraints

Start Over You searched for: Author "Leitch, Heather" Remove constraint Author: "Leitch, Heather"
495 results on '"Leitch, Heather"'

Search Results

1. Thermodynamics of hybrid quantum rotor devices

2. Heat transport in quantum devices

4. Exploiting coherence for quantum thermodynamic advantage

5. Driven quantum harmonic oscillators: A working medium for thermal machines

6. Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes

10. Improvement in quality of life in MDS patients who become transfusion independent after treatment.

11. Differences in Physician Burnout by Specialty: A Cross-Sectional Survey.

13. Revised 15-item MDS-specific frailty scale maintains prognostic potential

16. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

22. Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes

23. VEXAS syndrome: A review of bone marrow aspirate and biopsies reporting myeloid and erythroid precursor vacuolation

24. A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registry

25. The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry

29. A natural history of lower-risk myelodysplastic syndromes with ring sideroblasts: an analysis of the MDS-CAN registry

30. High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes

33. Overall survival in lower IPSS risk MDS by receipt of iron chelation therapy, adjusting for patient‐related factors and measuring from time of first red blood cell transfusion dependence: an MDS‐CAN analysis

34. ITACA: A new validated international erythropoietic stimulating agent‐response score that further refines the predictive power of previous scoring systems

43. Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Patients with Lower-Risk Myelodysplastic Syndromes

48. Fatigue, However Measured, Continues to Refine Prognosis in Higher Risk MDS: An MDS-CAN Study

49. Patient‐reported fatigue refines prognosis in higher‐risk myelodysplastic syndromes (MDS): a MDS‐CAN study

Catalog

Books, media, physical & digital resources